Abstract Title:

Walnut consumption in hyperlipidemic patients.

Abstract Source:

Angiology. 2005 Sep-Oct;56(5):581-3. PMID: 16193197

Abstract Author(s):

M J Zibaeenezhad, S J Shamsnia, M Khorasani

Article Affiliation:

Cardiovascular Research Center, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran. [email protected]

Abstract:

Walnut (Juglans regia L.) is described as an anticancer, tonic, blood purifier, and detoxifier agent. It is said that nuts have favorable fatty acids and nutrients. This study was performed to determine the lipid-lowering properties of walnut in a population in Shiraz, Southern Iran. In a randomized case-control study, 52 volunteers were divided into 2 groups: Group A consumed walnuts, 20 grams per day for 8 weeks and the control group (group B) consumed no walnuts. Triglycerides, total high-density lipoprotein (HDL), and low-density lipoprotein (LDL) levels were checked for each subject prior to, after 4 weeks, and at 8 weeks after the beginning of the study. In group A, the mean plasma TG level dropped by 17.1% from the baseline and HDL cholesterol also increased significantly by 9%. It was shown that frequent consumption of nuts in the daily diet was associated with a potentially decreased risk of coronary artery disease by decreasing the level of triglyceride and increasing the level of HDL.

Study Type : Human Study

Print Options


Key Research Topics

This website is for information purposes only. By providing the information contained herein we are not diagnosing, treating, curing, mitigating, or preventing any type of disease or medical condition. Before beginning any type of natural, integrative or conventional treatment regimen, it is advisable to seek the advice of a licensed healthcare professional.

© Copyright 2008-2024 GreenMedInfo.com, Journal Articles copyright of original owners, MeSH copyright NLM.